Scholars Central

Conference abstractPublished 10 Oct 2020

Medication Safety Update During COVID-19

Authors: Fatima Yousef Ghethan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The COVID-19 pandemic and the response of the healthcare system initiates some challenges associated with some of medication shortages and needs of changes on the medication management workflow, additional evidence base associated with the pharmaceutical treatment of COVID-19 complications, and limited availability of personal protective equipment (PPE).the use of automated dispensing cabinets (ADCs). Including Accessing the ADC by using hygiene before and after touching any machine . In some organizations; they disable the fingerprint for users who might be wearing gloves and activate retinal scanning or entry of a username and password until biometric fingerprint identification can resume. If clean gloves are used when accessing the cabinet, they should be discarded before leaving the location, and use hand’s hygiene and store a container of the appropriate cleaning disinfectant nearby to allow those accessing the ADC to disinfect common touched points minimize the risk of contamination, the medications that already removed from the ADC shall not be returned to the specific bin or pocket from which they came. A common secure, oneway return bin should be used for returning unadministered medications to the pharmacy (including controlled substances).Maintaining safe practices in a case of requiring a documented witness, independent double check by another practitioner is a must when removing certain facility-defined high-alert medications from an unprofiled ADC or via override (bypassing the pharmacist’s review of a medication order to obtain a medication from the ADC when assessment of the patient indicates that a delay in therapy would harm the patient) and use ADC dispensing alerts to provide practitioners with critical information about new or unfamiliar medications given that many practitioners may be working outside their normal clinical practice area.hydroxychloroquine or chloroquine : the FDA is aware of reports of serious heart rhythm problems in patients with COVID-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin and other QT prolonging medicines. We are also aware of increased usage of these medicines through outpatient prescriptions

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Materials Engineering and Applications.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Materials Engineering and Applications
  • SubjectEngineering
  • SubjectMaterials Science
  • BylineArticles whose byline prints “Fatima Yousef Ghethan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels